Location History:
- Lecco, IT (2009 - 2010)
- Martinsried, DE (2008 - 2012)
Company Filing History:
Years Active: 2008-2012
Title: Fabio Spreafico: Innovator in Lipolytic Enzymes
Introduction
Fabio Spreafico is a notable inventor based in Martinsried, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of novel enzymes. With a total of 5 patents, his work has implications for both industrial processes and medical diagnostics.
Latest Patents
Spreafico's latest patents include groundbreaking inventions related to lipases and phospholipases. The first patent focuses on a newly identified polynucleotide sequence that encodes a novel lipolytic enzyme. This invention features the full-length nucleotide sequence of the gene, the cDNA sequence comprising the full-length coding sequence, and the amino acid sequence of the functional protein. Additionally, it outlines methods for using these enzymes in industrial processes and diagnosing fungal infections. The second patent similarly relates to a novel phospholipase, detailing its polynucleotide sequence and potential applications in various fields.
Career Highlights
Fabio Spreafico is currently associated with Dsm IP Assets B.V., where he continues to innovate in enzyme technology. His work has not only advanced scientific understanding but also provided practical solutions for industry and healthcare.
Collaborations
Spreafico collaborates with esteemed colleagues such as Christian Wagner and Dieter Maier, contributing to a dynamic research environment that fosters innovation.
Conclusion
Fabio Spreafico's contributions to the field of biotechnology through his patents on lipases and phospholipases highlight his role as a leading inventor. His work continues to influence both industrial applications and medical diagnostics, showcasing the importance of innovation in science.